This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated Sep 2026 quarter versus Sep 2025: revenue up 11.7%, profit after tax up 13.9%
VASCONEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated Sep 2026 quarter versus Sep 2025: revenue rose 11.7% to Rs 25,209 lakh from Rs 22,563 lakh; profit after tax rose 13.9% to Rs 1,302 lakh from Rs 1,143 lakh. Unmodified reviews flagged the unresolved Almet dispute; consolidated half-year operating cash outflow was Rs 11,114 lakh. Board approved authorised capital of Rs 285 crore, up to 1.2 crore employee share options and an Rs 85 crore debt issue; approvals pending.
Profit growth helps, but negative cash flow, the Almet dispute, capital expansion, debt and employee options may pressure the stock or dilute holders.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹252.1 Cr | ₹225.6 Cr | +11.7% |
| Operating profit | ₹12.84 Cr | ₹11.53 Cr | +11.4% |
| Profit after tax | ₹13.02 Cr | ₹11.43 Cr | +13.9% |
| EBITDA margin | 7.5% | 7.0% | +0.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.